Morning Buzz: Allergan Plc (AGN), Facebook (FB), KaloBios (KBIO), General Electric (GE), Can-Fite BioPharma (CANF)

wall street

Pfizer Inc (PFE) on Monday said it would buy Botox maker Allergan Plc (AGN) in a $160-billion stock deal that will create the world’s largest drug maker.

The deal values Allergan’s shares at $363.63 each, representing a 16%  premium to the stock’s closing price of $312.46 on Friday.

Facebook (FB) — Chief Executive Officer Mark Zuckerberg announced on Friday that he would take a two-month paternity leave when his daughter arrives. Describing it as a “very personal decision”, the Facebook founder wrote: “Studies show that when working parents take time to be with their newborns, outcomes are better for the children and families.”

Shares of KaloBios Pharmaceuticals, Inc. (KBIO) soared more than 34% to hit a new record high of $26.65 on Monday on higher-than-average volume.

More than 2.7 million shares of the stock had changed hands by 10:06 a.m. ET, compared to the daily average volume of 1.17 million.

General Electric (GE) – The Fairfield, Connecticut-based company struck a deal to sell its $5.8 billion U.K. mortgage business to a consortium led by Blackstone.

Shares of Can-Fite BioPharma Ltd. (CANF) have risen nearly 32% in morning trading Monday after the company said the development of its drug candidate CF102 will be expanded beyond hepatocellular carcinoma, into treatment for non-alcoholic steatohepatitis.

Disclaimer: This page contains affiliate links. If you choose to make a purchase after clicking a link, we may receive a commission at no additional cost to you. Thank you for your support!

Be the first to comment

Leave a Reply

Your email address will not be published.


This site uses Akismet to reduce spam. Learn how your comment data is processed.